Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 512

1.

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.

Nho K, Kim S, Horgusluoglu E, Risacher SL, Shen L, Kim D, Lee S, Foroud T, Shaw LM, Trojanowski JQ, Aisen PS, Petersen RC, Jack CR Jr, Weiner MW, Green RC, Toga AW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

BMC Med Genomics. 2017 May 24;10(Suppl 1):29. doi: 10.1186/s12920-017-0267-0.

2.

The complexities underlying age-related macular degeneration: could amyloid beta play an important role?

Lynn SA, Keeling E, Munday R, Gabha G, Griffiths H, Lotery AJ, Ratnayaka JA.

Neural Regen Res. 2017 Apr;12(4):538-548. doi: 10.4103/1673-5374.205083. Review.

3.

Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012.

Hernandez I, Zhang Y.

Gerontol Geriatr Med. 2017 Apr 19;3:2333721417704946. doi: 10.1177/2333721417704946. eCollection 2017 Jan-Dec.

4.

Financial Capacity and Financial Exploitation of Older Adults: Research Findings, Policy Recommendations and Clinical Implications.

Wood S, Lichtenberg PA.

Clin Gerontol. 2017 Jan-Feb;40(1):3-13. doi: 10.1080/07317115.2016.1203382. Epub 2016 Jun 21.

PMID:
28452630
5.

Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer's Disease.

Johansson JU, Woodling NS, Shi J, Andreasson KI.

Curr Immunol Rev. 2015 Aug;11(2):125-131. doi: 10.2174/1573395511666150707181414.

6.

Translational synthetic biology.

Singh M, Vaidya A.

Syst Synth Biol. 2015 Dec;9(4):191-195. doi: 10.1007/s11693-015-9181-y. Epub 2015 Aug 18.

7.

Immunological memory to hyperphosphorylated tau in asymptomatic individuals.

Pascual G, Wadia JS, Zhu X, Keogh E, Kükrer B, van Ameijde J, Inganäs H, Siregar B, Perdok G, Diefenbach O, Nahar T, Sprengers I, Koldijk MH, der Linden EC, Peferoen LA, Zhang H, Yu W, Li X, Wagner M, Moreno V, Kim J, Costa M, West K, Fulton Z, Chammas L, Luckashenak N, Fletcher L, Holland T, Arnold C, Anthony Williamson R, Hoozemans JJ, Apetri A, Bard F, Wilson IA, Koudstaal W, Goudsmit J.

Acta Neuropathol. 2017 May;133(5):767-783. doi: 10.1007/s00401-017-1705-y. Epub 2017 Mar 24.

8.

Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.

Son SJ, Kim J, Park H.

PLoS One. 2017 Mar 23;12(3):e0173426. doi: 10.1371/journal.pone.0173426. eCollection 2017.

9.

Impact of the REACH II and REACH VA Dementia Caregiver Interventions on Healthcare Costs.

Nichols LO, Martindale-Adams J, Zhu CW, Kaplan EK, Zuber JK, Waters TM.

J Am Geriatr Soc. 2017 May;65(5):931-936. doi: 10.1111/jgs.14716. Epub 2017 Mar 13.

PMID:
28295134
10.

The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review.

Wen KX, Miliç J, El-Khodor B, Dhana K, Nano J, Pulido T, Kraja B, Zaciragic A, Bramer WM, Troup J, Chowdhury R, Ikram MA, Dehghan A, Muka T, Franco OH.

PLoS One. 2016 Dec 14;11(12):e0167201. doi: 10.1371/journal.pone.0167201. eCollection 2016.

11.

Goals of Care or Goals of Trust? How Family Members Perceive Goals for Dying Nursing Home Residents.

Rosemond C, Hanson LC, Zimmerman S.

J Palliat Med. 2017 Apr;20(4):360-365. doi: 10.1089/jpm.2016.0271. Epub 2016 Nov 29.

PMID:
27898281
12.

Effect of the Goals of Care Intervention for Advanced Dementia: A Randomized Clinical Trial.

Hanson LC, Zimmerman S, Song MK, Lin FC, Rosemond C, Carey TS, Mitchell SL.

JAMA Intern Med. 2017 Jan 1;177(1):24-31. doi: 10.1001/jamainternmed.2016.7031.

13.

Comparing Cognitive Profiles of Licensed Drivers with Mild Alzheimer's Disease and Mild Dementia with Lewy Bodies.

Yamin S, Stinchcombe A, Gagnon S.

Int J Alzheimers Dis. 2016;2016:6542962. Epub 2016 Sep 27.

14.

Morphometricity as a measure of the neuroanatomical signature of a trait.

Sabuncu MR, Ge T, Holmes AJ, Smoller JW, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):E5749-56. doi: 10.1073/pnas.1604378113. Epub 2016 Sep 9.

15.

Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.

Chen Y, Denny KG, Harvey D, Farias ST, Mungas D, DeCarli C, Beckett L.

Alzheimers Dement. 2017 Apr;13(4):399-405. doi: 10.1016/j.jalz.2016.07.151. Epub 2016 Aug 30.

PMID:
27590706
16.

THE ROLE OF CYSTEINE PROTEASE IN ALZHEIMER DISEASE.

Hasanbasic S, Jahic A, Karahmet E, Sejranic A, Prnjavorac B.

Mater Sociomed. 2016 Jun;28(3):235-8. doi: 10.5455/msm.2016.28.235-238. Epub 2016 Jun 1. Review.

17.

Predicting the role of assistive technologies in the lives of people with dementia using objective care recipient factors.

Czarnuch S, Ricciardelli R, Mihailidis A.

BMC Geriatr. 2016 Jul 20;16:143. doi: 10.1186/s12877-016-0314-2.

18.

The association between caregiver well-being and care provided to persons with Alzheimer's disease and related disorders.

Hazzan AA, Shannon H, Ploeg J, Raina P, Gitlin LN, Oremus M.

BMC Res Notes. 2016 Jul 18;9:344. doi: 10.1186/s13104-016-2150-z.

19.
20.

Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.

Spangenberg EE, Green KN.

Brain Behav Immun. 2017 Mar;61:1-11. doi: 10.1016/j.bbi.2016.07.003. Epub 2016 Jul 6. Review.

PMID:
27395435

Supplemental Content

Support Center